Indeed, AKR1B10 was found to be up-regulated in association with serum α-FP and to be an independent risk factor for HCC in CHC patients, implying a role in early-stage hepatocarcinogenesis [113]. Here, AKR1B10 is linked to hepatocellular carcinoma.